Literature DB >> 24275724

Pelvic inflammatory disease: identifying research gaps--proceedings of a workshop sponsored by Department of Health and Human Services/National Institutes of Health/National Institute of Allergy and Infectious Diseases, November 3-4, 2011.

Toni Darville1.   

Abstract

In November 2011, the National Institutes of Health convened a workshop of basic researchers, epidemiologists, and clinical experts in pelvic inflammatory disease to identify research gaps hindering advances in diagnosis, treatment, and prevention. This article summarizes the presentations, discussions, and conclusions of this group and highlights significant controversies that reveal aspects of pelvic inflammatory disease research that would most greatly benefit from the application of newer molecular, immunologic, and radiologic techniques. Multiple limitations to performing new clinical trials exist; however, emerging data from ongoing clinical trials will add to the current body of knowledge regarding prevention and treatment strategies. In addition, use of established health care databases could serve as a valuable tool for performance of unbiased epidemiologic outcome studies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24275724      PMCID: PMC5911392          DOI: 10.1097/OLQ.0000000000000028

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  55 in total

1.  Transvaginal power Doppler findings in laparoscopically proven acute pelvic inflammatory disease.

Authors:  P Molander; J Sjöberg; J Paavonen; B Cacciatore
Journal:  Ultrasound Obstet Gynecol       Date:  2001-03       Impact factor: 7.299

2.  Centers for Disease Control guidelines for prevention and control of Chlamydia trachomatis infections. Summary and Commentary.

Authors:  T A Bell; J T Grayston
Journal:  Ann Intern Med       Date:  1986-04       Impact factor: 25.391

3.  Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial.

Authors:  Roberta B Ness; David E Soper; Robert L Holley; Jeffrey Peipert; Hugh Randall; Richard L Sweet; Steven J Sondheimer; Susan L Hendrix; Antonio Amortegui; Giuliana Trucco; Thomas Songer; Judith R Lave; Sharon L Hillier; Debra C Bass; Sheryl F Kelsey
Journal:  Am J Obstet Gynecol       Date:  2002-05       Impact factor: 8.661

4.  Bacterial vaginosis: identifying research gaps proceedings of a workshop sponsored by DHHS/NIH/NIAID.

Authors:  Jeanne M Marrazzo; David H Martin; D Heather Watts; Joann Schulte; Jack D Sobel; Sharon L Hillier; Carolyn Deal; David N Fredricks
Journal:  Sex Transm Dis       Date:  2010-12       Impact factor: 2.830

5.  Mycoplasma genitalium: prevalence and behavioural risk factors in the general population.

Authors:  Berit Andersen; Ineta Sokolowski; Lars Østergaard; Jens Kjølseth Møller; Frede Olesen; Jørgen Skov Jensen
Journal:  Sex Transm Infect       Date:  2006-11-07       Impact factor: 3.519

6.  Markedly elevated plasma myeloperoxidase protein in patients with pelvic inflammatory disease who have A allele myeloperoxidase gene polymorphism.

Authors:  Shun-An Lee; Po-Hui Wang; Hui-Ling Chiou; Ming-Chin Chou; Hsiu-Ting Tsai; Shun-Fa Yang
Journal:  Fertil Steril       Date:  2009-01-14       Impact factor: 7.329

7.  Microbiological and histopathological findings in acute pelvic inflammatory disease.

Authors:  J Paavonen; K Teisala; P K Heinonen; R Aine; S Laine; M Lehtinen; A Miettinen; R Punnonen; P Grönroos
Journal:  Br J Obstet Gynaecol       Date:  1987-05

8.  Ectopic pregnancy and antibodies to Chlamydia trachomatis.

Authors:  L Svensson; P A Mårdh; M Ahlgren; F Nordenskjöld
Journal:  Fertil Steril       Date:  1985-09       Impact factor: 7.329

9.  Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results.

Authors:  L Weström; R Joesoef; G Reynolds; A Hagdu; S E Thompson
Journal:  Sex Transm Dis       Date:  1992 Jul-Aug       Impact factor: 2.830

10.  Is Mycoplasma genitalium in women the "New Chlamydia?" A community-based prospective cohort study.

Authors:  Pippa Oakeshott; Adamma Aghaizu; Phillip Hay; Fiona Reid; Sally Kerry; Helen Atherton; Ian Simms; David Taylor-Robinson; Birthe Dohn; Jorgen S Jensen
Journal:  Clin Infect Dis       Date:  2010-10-13       Impact factor: 9.079

View more
  10 in total

1.  Interleukin-10 modulates antigen presentation by dendritic cells through regulation of NLRP3 inflammasome assembly during Chlamydia infection.

Authors:  Yusuf Omosun; Danielle McKeithen; Khamia Ryans; Caroline Kibakaya; Uriel Blas-Machado; Duo Li; Rajesh Singh; Koichi Inoue; Zhi-Gang Xiong; Francis Eko; Carolyn Black; Joseph Igietseme; Qing He
Journal:  Infect Immun       Date:  2015-09-14       Impact factor: 3.441

2.  Discovery of Blood Transcriptional Endotypes in Women with Pelvic Inflammatory Disease.

Authors:  Xiaojing Zheng; Catherine M O'Connell; Wujuan Zhong; Uma M Nagarajan; Manoj Tripathy; De'Ashia Lee; Ali N Russell; Harold Wiesenfeld; Sharon Hillier; Toni Darville
Journal:  J Immunol       Date:  2018-03-12       Impact factor: 5.422

Review 3.  Update on Chlamydia trachomatis Vaccinology.

Authors:  Luis M de la Maza; Guangming Zhong; Robert C Brunham
Journal:  Clin Vaccine Immunol       Date:  2017-04-05

4.  A Commentary on Current Diagnostic Challenges and Research Needs for Evaluating Reproductive Sequelae of Sexually Transmitted Infections.

Authors:  Ellen N Kersh; William M Geisler
Journal:  J Infect Dis       Date:  2021-08-16       Impact factor: 5.226

5.  Computational modeling of TC0583 as a putative component of the Chlamydia muridarum V-type ATP synthase complex and assessment of its protective capabilities as a vaccine antigen.

Authors:  Delia F Tifrea; Michael L Barta; Sukumar Pal; P Scott Hefty; Luis M de la Maza
Journal:  Microbes Infect       Date:  2015-12-17       Impact factor: 2.700

6.  In vitro rescue of genital strains of Chlamydia trachomatis from interferon-γ and tryptophan depletion with indole-positive, but not indole-negative Prevotella spp.

Authors:  Noa Ziklo; Wilhelmina M Huston; Kuong Taing; Mohammad Katouli; Peter Timms
Journal:  BMC Microbiol       Date:  2016-12-03       Impact factor: 3.605

7.  Anti-Inflammatory Effect of Feiyangchangweiyan Capsule on Rat Pelvic Inflammatory Disease through JNK/NF-κB Pathway.

Authors:  Yao Li; Yang Liu; Qian Yang; Zhihui Shi; Yanhua Xie; Siwang Wang
Journal:  Evid Based Complement Alternat Med       Date:  2018-02-28       Impact factor: 2.629

8.  The immunoregulatory role of alpha enolase in dendritic cell function during Chlamydia infection.

Authors:  Khamia Ryans; Yusuf Omosun; Danielle N McKeithen; Tankya Simoneaux; Camilla C Mills; Nathan Bowen; Francis O Eko; Carolyn M Black; Joseph U Igietseme; Qing He
Journal:  BMC Immunol       Date:  2017-05-19       Impact factor: 3.615

9.  Structural and Immunological Characterization of Novel Recombinant MOMP-Based Chlamydial Antigens.

Authors:  Guillermo Madico; Olga Gursky; Jeff Fairman; Paola Massari
Journal:  Vaccines (Basel)       Date:  2017-12-25

10.  Is there a place for a molecular diagnostic test for pelvic inflammatory disease in primary care? An exploratory qualitative study.

Authors:  Helen Bittleston; Jane S Hocking; Jane L Goller; Jacqueline Coombe; Deborah Bateson; Sally Sweeney; Kirsteen Fleming; Wilhelmina M Huston
Journal:  PLoS One       Date:  2022-09-19       Impact factor: 3.752

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.